Director, President and CEO · Ovid Therapeutics Inc. · Common Stock
Side
SELL
Value
$17K
Shares
11.7K
Price
$1.45
Executed
Feb 23, 2026
Disclosed
Mar 2, 2026
Disclosure timeline7 days from execution to publication · legal deadline 2 business days
Feb 23 executedMar 2, 2026 disclosed
OVID · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 5 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Alexander Margaret A. filed this Form 4 reporting a open-market sale of OVID on Feb 23, 2026. It became public on Mar 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Alexander Margaret A.cik:0002036798
Issuer
Ovid Therapeutics Inc.cik:0001636651
Revision history · 0
No field has changed since this record was first ingested.
